Among the family members, EPHA2 and EPHB4 are the most studied in breast cancer and additionally EPHA4, EPHA7 and EPHB6 emerged as promising clinical candidates in an expression profile of the individual EPH and ephrin family members [16]. Here, EPHB4 is linked to breast carcinoma.